Literature DB >> 25481646

Two functional polymorphisms of ROCK2 enhance arterial stiffening through inhibiting its activity and expression.

Yi-Chu Liao1, Ping-Yen Liu2, Hsiu-Fen Lin3, Wen-Yi Lin4, James K Liao5, Suh-Hang H Juo6.   

Abstract

Derangement of Rho-associated kinases (ROCKs) has been related to coronary artery disease and stroke. ROCK2, rather than ROCK1, plays a predominant role in vascular contractility. The present study aims to test (1) the associations between ROCK2 single nucleotide polymorphisms (SNPs) and arterial stiffness, and (2) the molecular mechanism accounting for their effects. Stiffness parameters including beta (β), elasticity modulus (Ep) and pulse wave velocity (PWV) were obtained by carotid ultrasonography. Seven tagging SNPs of ROCK2 were initially genotyped in 856 subjects and significant SNPs were replicated in another group of 527 subjects. Two SNPs in complete linkage disequilibrium were found to be significantly associated with arterial stiffness. The major alleles of rs978906 (A allele) and rs9808232 (C allele) were associated with stiffer arteries. SNP rs978906 was predicted to influence microRNA(miR)-1183 binding to ROCK2, while rs9808232 causes amino acid substitution. To determine their functional impact, plasmid constructs carrying different alleles of the significant SNPs were created. Compared to rs978906G-allele constructs, cells transfected with rs978906A-allele constructs had higher baseline luciferase activities and were less responsive to miR-1183 changes. Oxidized-low density lipoprotein (Ox-LDL) suppressed miR-1183 levels and increased ROCK2 protein amounts. For rs9808232, cells transfected with C-allele constructs had significantly higher ROCK activities than those with A-allele constructs. Leukocyte ROCK activities were further measured in 52 healthy subjects. The average ROCK activity was highest in human subjects with CC genotype at rs9808232, followed by those with AC and lowest in AA. Taken together, the present study showed that two functional SNPs of ROCK2 increase susceptibility of arterial stiffness in the Chinese population. Non-synonymous SNP rs9808232 influences ROCK2 activity, while 3' UTR SNP rs978906 affects the ROCK2 protein synthesis by interfering miR-1183 binding.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Arterial stiffness; Polymorphisms; ROCK2; microRNAs

Mesh:

Substances:

Year:  2014        PMID: 25481646      PMCID: PMC4889447          DOI: 10.1016/j.yjmcc.2014.11.023

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  35 in total

Review 1.  Rho kinase, a promising drug target for neurological disorders.

Authors:  Bernhard K Mueller; Helmut Mack; Nicole Teusch
Journal:  Nat Rev Drug Discov       Date:  2005-05       Impact factor: 84.694

2.  ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice.

Authors:  O Nakagawa; K Fujisawa; T Ishizaki; Y Saito; K Nakao; S Narumiya
Journal:  FEBS Lett       Date:  1996-08-26       Impact factor: 4.124

3.  Mild association between the A/G polymorphism in the promoter of the apolipoprotein A-I gene and apolipoprotein A-I levels: a meta-analysis.

Authors:  S H Juo; D F Wyszynski; T H Beaty; H Y Huang; J E Bailey-Wilson
Journal:  Am J Med Genet       Date:  1999-01-29

4.  Association between the Thr431Asn polymorphism of the ROCK2 gene and risk of developing metastases of breast cancer.

Authors:  Mehmet E Kalender; Seniz Demiryürek; Serdar Oztuzcu; Ayse Kizilyer; Abdullah T Demiryürek; Alper Sevinc; Mustafa Dikilitas; Ramazan Yildiz; Celalettin Camci
Journal:  Oncol Res       Date:  2010       Impact factor: 5.574

5.  Roles of rho-associated kinase and oxidative stress in the pathogenesis of aortic stiffness.

Authors:  Kensuke Noma; Chikara Goto; Kenji Nishioka; Daisuke Jitsuiki; Takashi Umemura; Keiko Ueda; Masashi Kimura; Keigo Nakagawa; Tetsuya Oshima; Kazuaki Chayama; Masao Yoshizumi; James K Liao; Yukihito Higashi
Journal:  J Am Coll Cardiol       Date:  2007-01-26       Impact factor: 24.094

6.  Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation.

Authors:  Ping-Yen Liu; Yen-Wen Liu; Li-Jen Lin; Jyh-Hong Chen; James K Liao
Journal:  Circulation       Date:  2008-12-15       Impact factor: 29.690

7.  Let-7g improves multiple endothelial functions through targeting transforming growth factor-beta and SIRT-1 signaling.

Authors:  Yi-Chu Liao; Yung-Song Wang; Yuh-Cherng Guo; Wen-Lien Lin; Ming-Hung Chang; Suh-Hang Hank Juo
Journal:  J Am Coll Cardiol       Date:  2013-11-27       Impact factor: 24.094

8.  Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection.

Authors:  Sebastian Wolfrum; Andreas Dendorfer; Yoshiyuki Rikitake; Timothy J Stalker; Yulan Gong; Rosario Scalia; Peter Dominiak; James K Liao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-08-19       Impact factor: 8.311

9.  Association of genetic variants with chronic kidney disease in individuals with different lipid profiles.

Authors:  Tetsuro Yoshida; Kimihiko Kato; Kiyoshi Yokoi; Mitsutoshi Oguri; Sachiro Watanabe; Norifumi Metoki; Hidemi Yoshida; Kei Satoh; Yukitoshi Aoyagi; Yutaka Nishigaki; Yoshinori Nozawa; Yoshiji Yamada
Journal:  Int J Mol Med       Date:  2009-08       Impact factor: 4.101

10.  Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase.

Authors:  Masao Takemoto; Jianxin Sun; Junko Hiroki; Hiroaki Shimokawa; James K Liao
Journal:  Circulation       Date:  2002-07-02       Impact factor: 29.690

View more
  5 in total

Review 1.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

Review 2.  Druggable targets in the Rho pathway and their promise for therapeutic control of blood pressure.

Authors:  Rachel A Dee; Kevin D Mangum; Xue Bai; Christopher P Mack; Joan M Taylor
Journal:  Pharmacol Ther       Date:  2018-09-04       Impact factor: 12.310

3.  Arterial stiffness and stroke: de-stiffening strategy, a therapeutic target for stroke.

Authors:  Yajing Chen; Fanxia Shen; Jianrong Liu; Guo-Yuan Yang
Journal:  Stroke Vasc Neurol       Date:  2017-03-17

Review 4.  RhoGTPase in Vascular Disease.

Authors:  Derek Strassheim; Evgenia Gerasimovskaya; David Irwin; Edward C Dempsey; Kurt Stenmark; Vijaya Karoor
Journal:  Cells       Date:  2019-06-06       Impact factor: 6.600

5.  Vascular Tissue Specific miRNA Profiles Reveal Novel Correlations with Risk Factors in Coronary Artery Disease.

Authors:  Katrīna D Neiburga; Baiba Vilne; Sabine Bauer; Dario Bongiovanni; Tilman Ziegler; Mark Lachmann; Simon Wengert; Johann S Hawe; Ulrich Güldener; Annie M Westerlund; Ling Li; Shichao Pang; Chuhua Yang; Kathrin Saar; Norbert Huebner; Lars Maegdefessel; Rüdiger Lange; Markus Krane; Heribert Schunkert; Moritz von Scheidt
Journal:  Biomolecules       Date:  2021-11-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.